Skip to main content
Top
Published in: Journal of Neurology 12/2019

01-12-2019 | Multiple Sclerosis | Original Communication

Spinal cord lesions are frequently asymptomatic in relapsing–remitting multiple sclerosis: a retrospective MRI survey

Authors: Franco Granella, Elena Tsantes, Stefania Graziuso, Veronica Bazzurri, Girolamo Crisi, Erica Curti

Published in: Journal of Neurology | Issue 12/2019

Login to get access

Abstract

Background

Spinal cord (SC) involvement correlates with poor prognosis in patients with multiple sclerosis (MS). Nevertheless, there is no consensus on the use of SC-MRI at follow-up, mainly because of the belief that SC lesions are nearly always symptomatic.

Objectives

The aim of the present study was to investigate the frequency of asymptomatic SC combined unique activity (CUA, new/enlarging T2 or gadolinium-positive [Gd+] lesions) on MRI in a cohort of patients diagnosed with clinically isolated syndrome (CIS) or relapsing–remitting MS (RRMS).

Methods

We retrospectively investigated all scans showing SC-CUA in patients with CIS or RRMS referred to a single Italian MS centre. We determined whether they were symptomatic and whether they had associated brain radiological activity.

Results

In 340 SC-MRI scans with SC-CUA (230 patients), SC-CUA was asymptomatic in 31.2%; 12.1% of SC-CUA had neither clinical activity nor brain radiological activity (44.5% and 25.4%, respectively, considering only follow-up SC-CUA). At multivariate analysis asymptomatic SC-CUAs were associated with older age at onset (34.0 ± 10.37 vs 31.0 ± 9.99 years, p = 0.006), non-spinal onset (76.4 vs 47.4%, p < 0.001), lower EDSS score at MRI (1.8 ± 0.93 vs 2.4 ± 1.28, p = 0.001) and lower number of Gd+ SC lesions (0.1 ± 0.33 vs 0.3 ± 0.54, p = 0.04), compared to symptomatic SC-CUAs.

Conclusions

A substantial proportion of our patients had SC-CUA without clinical symptoms and/or without concomitant brain MRI activity. In these patients, SC-CUA was the only sign of disease activity, suggesting that regular SC-MRI follow-up is required for reliable assessment of radiological activity and may improve the management of patients with MS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kearney H, Miller DH, Ciccarelli O (2015) Spinal cord MRI in multiple sclerosis—diagnostic, prognostic and clinical value. Nat Rev Neurol 11:327–338CrossRef Kearney H, Miller DH, Ciccarelli O (2015) Spinal cord MRI in multiple sclerosis—diagnostic, prognostic and clinical value. Nat Rev Neurol 11:327–338CrossRef
2.
go back to reference Muccilli A, Seyman E, Oh J (2018) Spinal cord MRI in multiple sclerosis. Neurol Clin 36:35–57CrossRef Muccilli A, Seyman E, Oh J (2018) Spinal cord MRI in multiple sclerosis. Neurol Clin 36:35–57CrossRef
3.
go back to reference Arrambide G, Rovira A, Sastre-Garriga J et al (2018) Spinal cord lesions: a modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor. Mult Scler 24:301–312CrossRef Arrambide G, Rovira A, Sastre-Garriga J et al (2018) Spinal cord lesions: a modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor. Mult Scler 24:301–312CrossRef
4.
go back to reference Brownlee WJ, Altmann DR, Alves Da Mota P et al (2017) Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome. Mult Scler 23:665–674CrossRef Brownlee WJ, Altmann DR, Alves Da Mota P et al (2017) Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome. Mult Scler 23:665–674CrossRef
5.
go back to reference Sombekke MH, Wattjes MP, Balk LJ et al (2013) Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology 80:69–75CrossRef Sombekke MH, Wattjes MP, Balk LJ et al (2013) Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology 80:69–75CrossRef
6.
go back to reference Okuda DT, Mowry EM, Cree BA et al (2011) Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 76:686–692CrossRef Okuda DT, Mowry EM, Cree BA et al (2011) Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 76:686–692CrossRef
7.
go back to reference Filippi M, Rocca MA, Ciccarelli O et al (2016) MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guideline. Lancet Neurol 15:292–303CrossRef Filippi M, Rocca MA, Ciccarelli O et al (2016) MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guideline. Lancet Neurol 15:292–303CrossRef
8.
go back to reference Traboulsee A, Simon JH, Stone L et al (2016) Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR Am J Neuroradiol 37:394–401CrossRef Traboulsee A, Simon JH, Stone L et al (2016) Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR Am J Neuroradiol 37:394–401CrossRef
9.
go back to reference Sormani MP, Bruzzi P (2013) MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials. Lancet Neurol 12:669–676CrossRef Sormani MP, Bruzzi P (2013) MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials. Lancet Neurol 12:669–676CrossRef
10.
go back to reference Wattjes MP, Rovira À, Miller D et al (2015) Evidence based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients. Nat Rev Neurol 11:597–606PubMed Wattjes MP, Rovira À, Miller D et al (2015) Evidence based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients. Nat Rev Neurol 11:597–606PubMed
11.
go back to reference Cortese R, Ciccarelli O (2018) Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging—yes. Mult Scler 24:1536–1537CrossRef Cortese R, Ciccarelli O (2018) Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging—yes. Mult Scler 24:1536–1537CrossRef
12.
go back to reference Kearney H (2018) Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging—no. Mult Scler 24:1537–1539CrossRef Kearney H (2018) Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging—no. Mult Scler 24:1537–1539CrossRef
13.
go back to reference Zecca C, Disanto G, Sormani MP et al (2016) Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis. Mult Scler 22:782–791CrossRef Zecca C, Disanto G, Sormani MP et al (2016) Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis. Mult Scler 22:782–791CrossRef
14.
go back to reference Thorpe JW, Kidd D, Moseley IF et al (1996) Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 119:709–714CrossRef Thorpe JW, Kidd D, Moseley IF et al (1996) Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 119:709–714CrossRef
15.
go back to reference Ruggieri S, Logoteta A, Tinelli E et al (2018) Measuring disease activity in multiple sclerosis: the essential role of spinal cord MRI monitoring. ECTRIMS Online Library. Ruggieri S 2018; 228465 (P621) Ruggieri S, Logoteta A, Tinelli E et al (2018) Measuring disease activity in multiple sclerosis: the essential role of spinal cord MRI monitoring. ECTRIMS Online Library. Ruggieri S 2018; 228465 (P621)
16.
go back to reference Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173CrossRef Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173CrossRef
17.
go back to reference Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83:278–286CrossRef Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83:278–286CrossRef
18.
go back to reference Filippi M, Rocca MA, Bastianello S et al (2013) Guidelines from the Italian neurological and neuroradiological societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients. Neurol Sci 34:2085–2093CrossRef Filippi M, Rocca MA, Bastianello S et al (2013) Guidelines from the Italian neurological and neuroradiological societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients. Neurol Sci 34:2085–2093CrossRef
19.
go back to reference Sormani MP, Gasperini C, Romeo M et al (2016) Assessing response to interferon-b in a multicenter dataset of patients with MS. Neurology 87:134–140CrossRef Sormani MP, Gasperini C, Romeo M et al (2016) Assessing response to interferon-b in a multicenter dataset of patients with MS. Neurology 87:134–140CrossRef
20.
go back to reference Eckstein C, Syc S, Saidha S (2011) Differential diagnosis of longitudinally extensive transverse myelitis in adults. Eur Neurol J 3:27–39 Eckstein C, Syc S, Saidha S (2011) Differential diagnosis of longitudinally extensive transverse myelitis in adults. Eur Neurol J 3:27–39
Metadata
Title
Spinal cord lesions are frequently asymptomatic in relapsing–remitting multiple sclerosis: a retrospective MRI survey
Authors
Franco Granella
Elena Tsantes
Stefania Graziuso
Veronica Bazzurri
Girolamo Crisi
Erica Curti
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 12/2019
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09526-3

Other articles of this Issue 12/2019

Journal of Neurology 12/2019 Go to the issue

Pioneers in Neurology

Gaetano Rummo (1853–1917)